Genome-wide association study on overall survival of advanced non-small cell lung cancer patients treated with carboplatin and paclitaxel.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011 Jan 6 (1): 132-8.
Sato Yasunori, Yamamoto Noboru, Kunitoh Hideo, Ohe Yuichiro, Minami Hironobu, Laird Nan M, Katori Noriko, Saito Yoshiro, Ohnami Sumiko, Sakamoto Hiromi, Sawada Jun-Ichi, Saijo Nagahiro, Yoshida Teruhiko, Tamura Tomohi
Genome-wide association scan detected candidate polymorphisms associated with overall survival (OS) in advanced non-small cell lung cancer (NSCLC) treated with carboplatin (CBDCA) and paclitaxel (PTX).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 May 27 (15_suppl): 8031.
Sato Y, Yamamoto N, Kunitoh H, Ohe Y, Katori N, Sawada J, Sakamoto H, Saijo N, Yoshida T, Tamura